A quantitative analysis of brain soluble tau and the tau secretion factor

Pengcheng Han, Geidy Serrano, Thomas G. Beach, Richard John Caselli, Junxiang Yin, Ningning Zhuang, Jiong Shi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Neurofibrillary tangles (NFTs) represent products of insoluble tau protein in the brains of patients with Alzheimer disease (AD). The cerebrospinal fluid (CSF) tau level is a biomarker in AD diagnosis. The soluble portion of tau protein in brain parenchyma is presumably the source for CSF tau but this has not previously been quantified. We measured CSF tau and soluble brain tau at autopsy in temporal and frontal brain tissue samples from 7 cognitive normal, 12 mild cognitively impaired, and 19 AD subjects. Based on the measured brain soluble tau, we calculated the whole brain tau load and estimated tau secretion factor. Our results suggest that the increase in NFT in AD is likely attributable to post-translational processes; the increase in CSF tau in AD patients is due to an accelerated carrier-based secretion. Moreover, cognitive dysfunction assessed by final Mini-Mental State Examination scores correlated with the secretion factor but not with the soluble tau.

Original languageEnglish (US)
Pages (from-to)44-51
Number of pages8
JournalJournal of Neuropathology and Experimental Neurology
Volume76
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Alzheimer Disease
Cerebrospinal Fluid
Brain
tau Proteins
Neurofibrillary Tangles
Autopsy
Biomarkers

Keywords

  • Alzheimer disease
  • Soluble tau
  • Tau protein

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

A quantitative analysis of brain soluble tau and the tau secretion factor. / Han, Pengcheng; Serrano, Geidy; Beach, Thomas G.; Caselli, Richard John; Yin, Junxiang; Zhuang, Ningning; Shi, Jiong.

In: Journal of Neuropathology and Experimental Neurology, Vol. 76, No. 1, 2017, p. 44-51.

Research output: Contribution to journalArticle

Han, Pengcheng ; Serrano, Geidy ; Beach, Thomas G. ; Caselli, Richard John ; Yin, Junxiang ; Zhuang, Ningning ; Shi, Jiong. / A quantitative analysis of brain soluble tau and the tau secretion factor. In: Journal of Neuropathology and Experimental Neurology. 2017 ; Vol. 76, No. 1. pp. 44-51.
@article{3ef7963622a44bba9c3d0958ce719263,
title = "A quantitative analysis of brain soluble tau and the tau secretion factor",
abstract = "Neurofibrillary tangles (NFTs) represent products of insoluble tau protein in the brains of patients with Alzheimer disease (AD). The cerebrospinal fluid (CSF) tau level is a biomarker in AD diagnosis. The soluble portion of tau protein in brain parenchyma is presumably the source for CSF tau but this has not previously been quantified. We measured CSF tau and soluble brain tau at autopsy in temporal and frontal brain tissue samples from 7 cognitive normal, 12 mild cognitively impaired, and 19 AD subjects. Based on the measured brain soluble tau, we calculated the whole brain tau load and estimated tau secretion factor. Our results suggest that the increase in NFT in AD is likely attributable to post-translational processes; the increase in CSF tau in AD patients is due to an accelerated carrier-based secretion. Moreover, cognitive dysfunction assessed by final Mini-Mental State Examination scores correlated with the secretion factor but not with the soluble tau.",
keywords = "Alzheimer disease, Soluble tau, Tau protein",
author = "Pengcheng Han and Geidy Serrano and Beach, {Thomas G.} and Caselli, {Richard John} and Junxiang Yin and Ningning Zhuang and Jiong Shi",
year = "2017",
doi = "10.1093/jnen/nlw105",
language = "English (US)",
volume = "76",
pages = "44--51",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - A quantitative analysis of brain soluble tau and the tau secretion factor

AU - Han, Pengcheng

AU - Serrano, Geidy

AU - Beach, Thomas G.

AU - Caselli, Richard John

AU - Yin, Junxiang

AU - Zhuang, Ningning

AU - Shi, Jiong

PY - 2017

Y1 - 2017

N2 - Neurofibrillary tangles (NFTs) represent products of insoluble tau protein in the brains of patients with Alzheimer disease (AD). The cerebrospinal fluid (CSF) tau level is a biomarker in AD diagnosis. The soluble portion of tau protein in brain parenchyma is presumably the source for CSF tau but this has not previously been quantified. We measured CSF tau and soluble brain tau at autopsy in temporal and frontal brain tissue samples from 7 cognitive normal, 12 mild cognitively impaired, and 19 AD subjects. Based on the measured brain soluble tau, we calculated the whole brain tau load and estimated tau secretion factor. Our results suggest that the increase in NFT in AD is likely attributable to post-translational processes; the increase in CSF tau in AD patients is due to an accelerated carrier-based secretion. Moreover, cognitive dysfunction assessed by final Mini-Mental State Examination scores correlated with the secretion factor but not with the soluble tau.

AB - Neurofibrillary tangles (NFTs) represent products of insoluble tau protein in the brains of patients with Alzheimer disease (AD). The cerebrospinal fluid (CSF) tau level is a biomarker in AD diagnosis. The soluble portion of tau protein in brain parenchyma is presumably the source for CSF tau but this has not previously been quantified. We measured CSF tau and soluble brain tau at autopsy in temporal and frontal brain tissue samples from 7 cognitive normal, 12 mild cognitively impaired, and 19 AD subjects. Based on the measured brain soluble tau, we calculated the whole brain tau load and estimated tau secretion factor. Our results suggest that the increase in NFT in AD is likely attributable to post-translational processes; the increase in CSF tau in AD patients is due to an accelerated carrier-based secretion. Moreover, cognitive dysfunction assessed by final Mini-Mental State Examination scores correlated with the secretion factor but not with the soluble tau.

KW - Alzheimer disease

KW - Soluble tau

KW - Tau protein

UR - http://www.scopus.com/inward/record.url?scp=85019745942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019745942&partnerID=8YFLogxK

U2 - 10.1093/jnen/nlw105

DO - 10.1093/jnen/nlw105

M3 - Article

C2 - 28069930

AN - SCOPUS:85019745942

VL - 76

SP - 44

EP - 51

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 1

ER -